Growth failure in Children.pptx

1,950 views 46 slides Dec 08, 2022
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

growth failure in children


Slide Content

Dr.Azad A Haleem AL.Mezori MRCPCH,DCH, FIBMS Assistant Professor University Of Duhok College of Medicine Pediatrics Department [email protected] Growth Failure in Children

Growth Growth refers to an increase in physical size of the whole body or any of its parts. It is simply a quantitative change in the child ’ s body. It can be measured in Kg, pounds, meters, inches, … .. etc

Development Development refers to a progressive increase in skill and capacity of function. It is a qualitative change in the child ’ s functioning. It can be measured through observation.

Introduction Growth failure is one of the most common presentation to a pediatrician . Most short children have physiological causes not requiring evaluation . The aim of evaluation of growth failure is to avoid unnecessary work - up in children with physiological causes while not missing a pathological cause . 

Definition Short child: Any child whose height falls below the 3rd centile for his/her community. Failure of physical growth The term ‘Dwarfism’ is no longer used for short stature Approximately 3% children in any population will be short .

PATHOPHYSIOLOGY  An understanding of growth physiology is of most importance for successful management of growth disorders .

GROWTH PATTERN: Growth is characterized by phases of rapid growth ( intrauterine , infancy and puberty ) interspersed with reduced growth ( childhood ) Maximum linear growth happens in the fetal period with increase of 50 cm . Fetal growth is regulated by intrauterine environment with limited impact of growth hormone and thyroxine . Infancy is associated with gain of 25 cm in first year and 12 cm in the second. Growth during this period is largely driven by nutrition .

Childhood growth contributes significantly to adult height and occurs at a steady rate of 5-6 cm per year . Puberty accounts for 20-25 cm of growth . Pubertal growth spurt starts at breast stage II in girls and testicular volume of 10 ml in boys and lasts for two years . It peaks at breast stage IV 6 months prior to menarche with a rate of 9 cm / year in girls and a testicular volume of 15 ml with a rate of 11 cm / year in boys . 

GROWTH REGULATION  Final height is determined by genetics explaining 60-80 % variation . Within this framework growth represents an interaction of nutrition and endocrine factors . Nutrition plays vital role in growth regulation . Type 1 nutrients ( vitamins , calcium , iodine and magnesium ) play a role in specific processes . There deficiency disrupts a unique facet with normal overall growth . Type II nutrients are the building blocks of body ( proteins , electrolytes , zinc , phosphorus and sulfate ) . Their deficiency causes global reduction in growth . 

ENDOCRINE REGULATION  Growth is regulated by the GHRH - GH - IGF1 axis with inputs from nutritional signals , sex steroids and thyroxine .  Growth hormone - IGF1 axis  Hypothalamic GHRH acts on pituitary to produce growth hormone . Growth hormone is secreted in pulsatile fashion with maximum release at night . Growth hormone acts on the liver to produce IGF I , which acts on the type I IGF receptor on the growth plate to induce growth . 

Nutritional influence  Malnutrition is a growth hormone resistant state with high GH and low IGF1 levels. GHD may therefore be missed in children with malnutrition . Overnutrition is a growth hormone sensitive state with high IGFI and low growth hormone levels . This may lead to erroneous diagnosis of growth hormone deficiency in obesity. Increased insulin in obesity stimulates growth by raising free IGF1 levels and acting on the type I IGF receptor .

CRITERIA  Growth failure evaluation is required for children who are: very short ( height less than 1st percentile) , short and not growing ( height between 1 to 3rd percentile and not growing at all ( crossing two or more major percentile lines between the age of 2 years and puberty ) . Growth velocity should be measured over a period of at least 6 months to one year with age specific cutoff for identification of disorder . 

ETIOLOGY  Growth is controlled by multiple factors and abnormality in any of these may cause growth failure .

Short child Six GOLDEN POINTS 1- Accurate & Serial measures. 2-Pubertal assessment  3- Mid Parental Height (MPH). 4- Height age. 5- Bone Age. 6- appropriates Investigations.

Important definitions Chronological age – Actual age of the child. Height age – it’s the age at which the height of the child is at 50 th centile. Bone age - is an indicator of skeletal maturation. Target MPH : F+M/2 +6.5 for boys and -6.5 for girls. Then plot the result on Growth Chart at Age 20 to form Family chart ±10 to form centile

Assessment of a child with short stature Accurate height measurement& height velocity Height plotted on appropriate growth chart.

Normal Measuring Supine length < 2 y of age For measurement of supine length it is best to use a firm box with an inflexible board against which the head lies, with a movable footboard on which the feet are placed. Erect height > 2 y The head is held in a horizontal plane Upward pressure is applied to the mastoid processes in order to encourage the child to stand up straight.

 Growth charts  The key aspects to look in a growth chart include absolute status compared to population ( percentile ) , effect of parental height ( growth chart for the family ) and relative impact on height and weight ( height age and weight age ) . Greater compromise of weight than height in a short child suggests nutritional cause ( malnutrition , infection , renal tubular acidosis or celiac disease ) while height is more affected in endocrine causes .

 Pubertal assessmen  

 Pubertal assessment  Breast stage II ( elevation of papilla ) suggests that a girl has entered puberty and marks the initiation of growth spurt . Thelarche should be differentiated from lipomastia by palpating breast tissue between thumb and index finger . Breast stage IV ( secondary mound ) and vaginal discharge predict menarche within the next six months . Post menarchal growth is limited to 5-8 cm .

First sign of puberty in boys is increase in testicular size followed by appearance of pubic hairs and increase in penile length and thickness . Pubertal onset is marked by a testicular volume of 4 ml with growth spurt starting at 10 ml . Importantly growth velocity is lowest just before the onset of puberty . This results in frequent presentation of prepubertal boys with short stature . Spermarche is a terminal event indicating limited growth potential . 

Mid parental height (MPH) Comparison with child’s own genetic potentia Mid parental height for boys MPH = mother's height + father's height /2 + 6.5cm Mid parental height for girls MPH = mother's height + father's height /2 – 6.5cm Then plot the result on Growth Chart at Age 20 to form Family chart ±10 ( 6 )

Family Chart Example: 3 Y – girl – Ht=85 cm --Wt=10 Kg Father Ht= 165 cm Mother Ht= 155 cm MPH= 160-6.5= 153.5 Plot on age 20 153.5 ±10 143.5 – 163.5 3 rd MPH= 153.5±10

Height age Height of a person at the 50 th percentile for their age.

Height age Examples: Girl- Age = 5 y Ht= 95 cm Height age= ?

Bone age assessment  X ray of the non - dominant ( conventionally left ) hand and wrist is used for bone age assessment . The fingers should be widely spread to allow visualization of all bones separately . Given the difficulties of formal bone age assessment for busy physicians , practical method has been devised to provide quick overview of skeletal maturation . This involves selection of area of interest , comparison of different areas and overall estimation of bone age . The Greulich and Pyle Method The Tanner–Whitehouse Method Computerized Automatic Systems 

Carpal bones are preferred in infancy ( up to 10 months in girls and 14 months in boys ) followed by phalangeal epiphysis ( till 2 years in girls and 3 years in boys ) . Comparison of the size of epiphysis to metaphysis is indicated in pre - puberty to early / mid puberty . Epiphyses are smaller than metaphysis till seven years of age in girls and nine years in boys . They become equal to metaphysis by 10-12 years , bigger beyond 12 years with capping and fusion by 14 years of age. Fusion of distal epiphysis is assessed during late puberty ( 13-15 years in girls and 14-16 years in boys with focus on long bones subsequently .

epiphysis to metaphysis

PHYSIOLOGICAL CAUSES  These represent the vast majority of children with growth failure . Their identification limits unnecessary work - up for causes of growth failure

Familial Short Stature  In contradistinction to CDGP , children with familial short stature have normal bone age and puberty . The disorder is characterized by early onset growth failure , family history of short stature , normal growth velocity and compromised final height . Consideration for genetic cause of short stature should be given if either of the parent is very short ( height below -3 SDS ) or has characteristic clinical picture.

Is she short? Example: 3 Y – girl – Ht=85 cm --Wt=10 Kg Father Ht= 165 cm Mother Ht= 155 cm MPH= 160-6.5= 153.5 Plot on age 20 153.5 ±10 143.5 – 163.5 Bone Age = normal 50 th 3 rd MPH= 153.5±10 Familial short stature

Constitutional Delay Of Growth & Puberty ( CDGP )  CDGP is one of the commonest cause of growth failure . It is due to delayed onset of puberty due to genetic factors . Growth is normal in the initial phase with faltering by seven years of age . The child remains behind his peers despite a normal growth rate . Final height is normal as bone age is delayed and growth continues for a longer period than other children . Family history of delayed puberty ( delayed menarche in mother ; delayed onset of shaving and continued growth in college years in father ) is present . CDGP is common in boys but also frequently observed in girls.

Is she short? Example: 5.5 Y – girl Ht= 98 cm --Wt=13 Kg Father Ht= 175 cm Mother Ht= 165 cm MPH= 170-6.5= 163.5 ±10 HT Age=3.5 years Bone Age=3.5 years 50 th 3 rd MPH= 163.5 ±10 Constitutional short stature

Is she short? Example: 5 Y – girl – Ht= 98 cm --Wt=15 Kg Father Ht= 175 cm Mother Ht= 165 cm MPH= 170-6.5= 163.5 ±10 HT Age=3.5 years Bone Age=1 year 50 th 3 rd MPH= 163.5 ±10 Pathological short stature

PATHOLOGICAL CAUSES 

Endocrine Causes  Endocrine causes of growth failure include hypothyroidism , growth hormone deficiency , pseudohypoparathyroidism and Cushing syndrome . These children have preserved weight with delayed bone age and puberty .  Hypothyroidism-  Pseudohypoparathyroidism Cushing syndrome GH - IGF1 axis disorders

ASSESSMENT  Key aspects of evaluation of a short child is to confirm short stature , exclude physiological causes , differentiate nutritional from endocrine etiology and identification of the cause .  IS IT PHYSIOLOGICAL OR PATHOLOGICAL?

Investigations  Screening tests include complete blood count, erythrocyte sedimentation rate Electrolytes, calcium , phosphorus and alkaline phosphatase blood sugar creatinine ( chronic kidney disease ) alanine transferase ( liver disease ) free T4 , TSH levels ( hypothyroidism ) celiac disease screening chest X ray blood gas ( renal tubular acidosis ) Karyotype with 50 metaphases should be done in short girls with no apparent abnormality on screening tests to identify Turner syndrome . 

Assessment of GH - IGF1 axis  GH - IGF1 axis evaluation should be done only after exclusion of all other causes of growth failure . Basal GH has no role in diagnosing GHD but can help in screening for GH resistance . Normal thyroid and cortisol levels are essential to elicit growth hormone response . 

Growth hormone stimulation test is considered the gold standard for identifying GHD . Sex steroid priming is recommended in girls older than 10 years and boy above 11 years who are pre - pubertal and have predicted adult height in the normal range . 17 beta estradiol ( Progynova , 2 mg for two days) can be used in both boys and girls .

Commonly used stimuli include: clonidine ( 5 mcg / kg to a maximum dose of 200 mcg ) , glucagon ( 30 mcg / kg with a maximum dose of 1 mg ) and insulin ( 0.1 unit / kg to induce hypoglycemia ) . Complete GHD is defined as peak stimulated growth hormone lower than 5 ng / mL and partial GHD as levels between 5-10 ng / ml . Children with abnormal response to one test should have another dynamic test to establish the diagnosis . 

GH dependent peptides  IGF 1 and IGFBP3 are secreted in response to GH and provide information about GH effect . These peptides are used for screening for GHD and monitoring response to GH therapy . IGF 1 is an unreliable marker before two years of age and in those with malnutrition and liver disease . IGFBP3 is a better marker of growth hormone status in younger children including neonates .

MANAGEMENT  General measures include nutrition ( protein , zinc , iron and calcium supplementation ) and physical activity . Specific measures include gluten free diet in celiac disease , alkali in RTA , thyroxine in hypothyroidism and supplements and infection control in cystic fibrosis .

MANAGEMENT  Growth hormone therapy is indicated in children with: GHD ( benefit of 20-25 cm ) , Turner syndrome ( 10-15 cm ) , SGA without catchup ( gain 7-10 cm ) , chronic kidney disease planned for renal transplant and Prader Willi syndrome with growth failure . GH therapy is being increasingly used in children with idiopathic short stature with height below 1st percentile .

THANKS FOR YOUR ATTENTION
Tags